Aqilion
Helsingborg, SE · 1 known investors
Aqilion is a biotech company developing new treatments for diseases caused by chronic inflammation and dysfunctional immune reactions, including autoimmune diseases. It operates mainly in the early phases of drug discovery, from idea to clinical proof-of-concept, working through a partly virtual organization in collaboration with selected drug-development partners.
Biotech
Investors · 1
Frequently asked questions
- What does Aqilion do?
- Aqilion is a biotech company developing new treatments for diseases caused by chronic inflammation and dysfunctional immune reactions, including autoimmune diseases. It operates mainly in the early phases of drug discovery, from idea to clinical proof-of-concept, working through a partly virtual organization in collaboration with selected drug-development partners.
- Who are Aqilion's investors?
- Aqilion's investors include FSG.
- Where is Aqilion headquartered?
- Aqilion is headquartered in Helsingborg, SE.